Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05797909 · ClinicalTrials.gov registry record
The PCOS Challenge Study
A clinical trial of Polycystic Ovary Syndrome, sponsored by PCOS Challenge: The National Polycystic Ovary Syndrome Association.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT05797909: Recruiting study of Polycystic Ovary Syndrome, sponsored by PCOS Challenge: The National Polycystic Ovary Syndrome Association.
NCT05797909 is a study of Polycystic Ovary Syndrome that is actively recruiting participants, run by PCOS Challenge: The National Polycystic Ovary Syndrome Association. The registered enrollment target is 15,000 participants, below the 16,758-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05797909, a study of Polycystic Ovary Syndrome, is actively recruiting participants, sponsored by PCOS Challenge: The National Polycystic Ovary Syndrome Association.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of The PCOS Challenge Study will be to conduct high-quality research where patients are included in the design, and answering the questions that patients identify as important to their lived experience with PCOS. In partnership with clinical investigators, patients will work on the development and management of data collection, the research agenda, and the sharing of research findings. The PCOSC Study will promote the advancement of research that provides reliable, useful, and meaningful information to patients with PCOS and their clinicians. The population for The PCOS Challenge Study will include individuals with a clinical diagnosis of PCOS, individuals self-diagnosed with PCOS, individuals with symptoms of PCOS (e.g., hirsutism, irregular menstrual cycles), and demographic-matched controls without PCOS.
Primary Outcome
Such as responses to survey questions
Conditions Studied
Study Locations (1)
Maryland
- PCOS Challenge: The National Polycystic Ovary Syndrome Association - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2022-06-22 |
| Est. Completion | 2042-12-31 |
What NCT05797909 shows while recruiting
NCT05797909 is an observational study that tracks outcomes without assigning an intervention. Its 15,000 participants enrollment target places it among the larger protocols in the corpus, below the 16,758-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (10% lower).
The record links to 1 condition, with Polycystic Ovary Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT05797909 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05797909 about?
NCT05797909 is a clinical study titled "The PCOS Challenge Study". The primary purpose of The PCOS Challenge Study will be to conduct high-quality research where patients are included in the design, and answering the questions that patients identify as important to their lived experience with PCOS. In partnership with clinical investigators, patients will work on t...
What is the current status of trial NCT05797909?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2022-06-22. Estimated completion is 2042-12-31.
What conditions does trial NCT05797909 study?
This clinical trial studies the following conditions: Polycystic Ovary Syndrome.
Who is sponsoring clinical trial NCT05797909?
This trial is sponsored by PCOS Challenge: The National Polycystic Ovary Syndrome Association, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05797909 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polycystic Ovary Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05797909's enrollment target sits among peer trials
15,000 2nd of 30 the highest of 30 other Polycystic Ovary Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Polycystic Ovary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Combined Oral Contraceptive Pill and Resistance Starch
RECRUITING · Phase 2
-
Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
RECRUITING · Early Phase 1
-
The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System
RECRUITING · NA
-
Apple Women's Health Study
RECRUITING
-
Fasting Insulin and HOMA-IR by Age, Sex, Race/Ethnicity, BMI, and PCOS Diagnosis
RECRUITING
-
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI